Gossamer Bio, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 49.17 million compared to USD 57.79 million a year ago. Basic loss per share from continuing operations was USD 0.52 compared to USD 0.76 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.694 USD | -4.93% | -6.92% | -23.95% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.95% | 165M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- GOSS Stock
- News Gossamer Bio, Inc.
- Gossamer Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023